Annovis Bio Inc (NYSE:ANVS) traded at $1.47 at close of the session on Tuesday, April 22 and made an upward move of 8.89% on its previous day’s price. Looking at the stock we see that its previous close was $1.35 and the beta (5Y monthly)
Annovis Bio Inc (NYSE:ANVS) shares, rose in value on Thursday, April 16, with the stock price down by -3.17% to the previous day’s close as strong demand from buyers drove the stock to $1.22. Actively observing the price movement in the last trading, the stock
In the biotechnology industry, companies produce drugs that treat illness and diagnostic technologies. For these products to be approved by the FDA, the process is lengthy and expensive. Food and Drug Administration (FDA). In this case, investors may have to wait years to find out
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
